Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Focus on Nutraceuticals & Natural Products: Medical Use of Cannabis

Posted on July 5th, 2017 by in Pharma R&D

These days, there is a lot of focus on nutraceuticals and ‘natural products’, derived from nature or alternately synthesized as ‘nature-identical compounds’ and used in nutraceuticals products. Continue reading “Focus on Nutraceuticals & Natural Products: Medical Use of Cannabis” »

Cost Saving: The trade-off that bites back

Posted on April 3rd, 2017 by in Pharma R&D

Making a trade-off between competing activities or priorities is a critical skill involved in developing a new medicine. This approach helps balance the risk of technical failure and investment to develop innovative products, an important consideration with such high failure rates in pharma R&D. Continue reading “Cost Saving: The trade-off that bites back” »

Working to Uncover the Mode of Action

Posted on March 2nd, 2017 by in Pharma R&D

The New Year has brought some new talent into the Myelo Therapeutics team. In January we welcomed Susann, our new postdoctoral researcher. We’re excited to have someone with her experience, which includes studying molecular biology in Dresden and Heidelberg, Continue reading “Working to Uncover the Mode of Action” »

Will 2017 be a Black Swan year?

Posted on February 6th, 2017 by in Pharma R&D

A few years ago, I sat with some friends aiming to make predictions for the year ahead. Our goal was to see how close we could get, with a plan to review the following new year. We made several predictions for the world of science Continue reading “Will 2017 be a Black Swan year?” »

  1. 1
  2. 2
  3. 3
  4. 4